Cancer BiologyOncogenePeer-reviewed
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer
Prachi Walke, Jared D. W. Price, Frederick S. Vizeacoumar…·Franco J. Vizeacoumar
This study identifies Neurog2 as a potential therapeutic target for MYCN-driven neuroendocrine prostate cancer by showing its role in promoting tumor growth and NEPC development.
3 citations